Therefore, in the context of inactivated vaccines against highly pathogenic influenza strains that could arise from animal reservoirs, the recall of dominant CD8+ T cell responses targeting the M and NP proteins most closely related to the emerging virus strains could be of great value in vaccine effectiveness. The gene discussed is CD8A; the disease is influenza.